Floatz logo

Aldhbr Umbilical Cord Blood Cells

MDS

Joanne Kurtzberg, MDCell therapyPhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

315 Active assets in the MDS cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB
Fludarabine
Sawa Ito, MD
Phase 4BB
Anti-Thymoglobulin, Rabbit
Peking University First Hospital
Phase 2/3BB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB

View all 50 →

Same molecule, other indications

Aldhbr Umbilical Cord Blood Cells is also rated in:

aplastic anemiaDormant
CC
Indicative ·
47 / 100
View asset →
metabolic diseaseDormant
CC
Indicative ·
47 / 100
View asset →
immunodeficiency diseaseDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →